Type and frequency of immune-related adverse reactions in patients treated with Pembrolizumab, a monoclonal antibody directed against PD-1, in advanced melanoma at Mayo Clinic in Jacksonville, Florida (or a single institution?)
applicable and available. Complaints and adverse reactions were grouped by organ system for detailed analysis. Treatment with glucocorticoids was also recorded. Results: 74 charts were reviewed, and 69 patients…

